Showing results (71-80 of 132) with videos related to
Sort By:
Pageof 14
Metabolism: Clinical and Experimental|September 1, 1992
Benefit from hypocaloric diet in obese men depends on the extent of weight-loss regarding cholesterol, and on a simultaneous change in body fat distribution regarding insulin sensitivity and glucose toleranceA C Sönnichsen, W O Richter, P SchwandtFortschritte Der Medizin|March 20, 1993
[Effect of three antihypertensive drug groups on lipid metabolism. Effects of alpha receptor blockers, central sympatholytic drugs and vasodilators]B G Jacob, W O Richter, P SchwandtInternational Journal of Tissue Reactions|January 1, 1991
Comparative effects of two HMG-CoA reductase inhibitors (lovastatin and pravastatin) on serum lipids and lipoproteinsW O Richter, B G Jacob, P SchwandtArtificial Organs|April 1, 1996
Short- and long-term effects on serum lipoproteins by three different techniques of apheresisW O Richter, M G Donner, P SchwandtArtificial Organs|March 7, 2002
RheoSorb: a specific adsorber for fibrinogen elimination in clinical situations with impaired rheologyR A Koll, J Klinkmann, W O RichterJournal of Cardiovascular Pharmacology|September 1, 1993
Long-term treatment (2 years) with the HMG CoA reductase inhibitors lovastatin or pravastatin in combination with cholestyramine in patients with severe primary hypercholesterolemiaB G Jacob, W O Richter, P SchwandtThe Clinical Investigator|November 1, 1993
Therapy of severe familial heterozygous hypercholesterolemia by low-density lipoprotein apheresis with immunoadsorption: effects of the addition of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors to therapyB G Jacob, W O Richter, P SchwandtFortschritte Der Medizin|July 20, 1997
[Homocysteine and coronary heart disease. Is slight or moderate homocysteinemia related to increased risk of coronary heart disease?]M G Donner, P Schwandt, W O RichterInternational Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|July 1, 1995
Dexfenfluramine inhibits catecholamine stimulated in vitro lipolysis in human fat cellsW O Richter, M G Donner, P SchwandtInternational Journal of Obesity|June 1, 1990
Reduction of lipoprotein (a) by weight lossA C Sönnichsen, W O Richter, P SchwandtPageof 14